Figure 1 Schematic diagram of AI eye feature imaging and a photo of the system. (a) Graphical representation of conventional eye imaging, including the illumination source's reflection shadows (b) Schematic diagram of AI eye feature imaging (c) Image of the AI eye feature imaging system (d) Graphical representation of shadow less white eye imaging in four directions.

Figure 2 Processing processes of the AI eye feature imaging and health analysis system

Figure 3Eight original eye images corresponding to two eye feature images.

Figure 4 Five main eye feature of diabetics.(a) "Yellow Area",(b)"Gray Speck", (c) "Spot", (d) "Hillock", and (e) "Moon Halo".

Figure 5 Eye feature images contrasting two TCHO patients. (A) Eye feature image of a patient whose TCHO level was 8.82mmol/L. The size is 4512pix, and S=50% in the HSB channel. (B) Eye feature image of a patient whose TCHO level was 4.66mmol/L. The size is 1052pix, and S=40% in the HSB channel.

Eye feature

Yellow Area

Gray Speck

Spot

Hillock

Moon Halo

Number

113

10

41

70

7

Ratio(%)

89.0

7.8

32.8

55.1

5.4

Table 1. Statistical Data of Eye Feature Classification of127 Diabetics.

Eye feature

Yellow Area

Gray Speck

Spot

Hillock

Moon Halo

Number

13

4

9

3

4

Ratio(%)

26.0

8.0

45.0

6.0

8.0

Table 2. Statistical Data of Eye Feature Classification of general Controls.

ID

Clinical

AI system

ID

Clinical

AI system

ID

Clinical

AI system

1

P

N

19

P

P

37

P

P

2

P

P

20

P

P

38

P

P

3

P

P

21

P

N

39

N

N

4

P

P

22

P

P

40

N

N

5

P

P

23

P

P

41

N

N

6

P

P

24

P

P

42

N

N

7

P

P

25

P

P

43

N

N

8

P

P

26

P

N

44

N

N

9

P

N

27

P

P

45

N

N

10

P

P

28

P

P

46

N

N

11

P

P

29

P

P

47

N

N

12

P

P

30

P

N

48

N

N

13

P

P

31

P

P

49

N

P

14

P

N

32

P

P

50

N

N

15

P

P

33

P

P

51

N

P

16

P

P

34

P

P

52

N

N

17

P

P

35

P

P

53

N

N

18

P

P

36

P

P

 

 

 

Table 3. Statistical data from the AI system diagnostic results of 38 diabetics and 15 general controls.

 

Normal type

Serious type

Moderate type

Normal value

TRIG（mmol/L）

1.57

1.97

1.77

<1.70

LDL（mmol/L）

3.19

3.64

3.43

<3.12

TCHO（mmol/L）

5.64

6.10

5.89

<5.72

Table 4. The average concentration of TRIG, LDL, and TCHO in different types of patients.

Patients type

N type

M type

P type

Proportion of patients whose TCHO was > 6.00mmol/L

20.0%

40.7%

60.7%

Table 5.The proportion of patients witha dangerous level of TCHO.